RESUMO
PURPOSE: The aim of this multi-center study was to assess the diagnostic capability of visual assessment in L-methyl-11C-methionine positron emission tomography (MET-PET) for differentiating a recurrent brain tumor from radiation-induced necrosis after radiotherapy, and to compare it to the accuracy of quantitative analysis. METHODS: A total of 73 brain lesions (glioma: 31, brain metastasis: 42) in 70 patients who underwent MET-PET were included in this study. Visual analysis was performed by comparison of MET uptake in the brain lesion with MET uptake in one of four regions (around the lesion, contralateral frontal lobe, contralateral area, and contralateral cerebellar cortex). The concordance rate and logistic regression analysis were used to evaluate the diagnostic ability of visual assessment. Receiver-operating characteristic curve analysis was used to compare visual assessment with quantitative assessment based on the lesion-to-normal (L/N) ratio of MET uptake. RESULTS: Interobserver and intraobserver κ-values were highest at 0.657 and 0.714, respectively, when assessing MET uptake in the lesion compared to that in the contralateral cerebellar cortex. Logistic regression analysis showed that assessing MET uptake in the contralateral cerebellar cortex with brain metastasis was significantly related to the final result. The highest area under the receiver-operating characteristic curve (AUC) with visual assessment for brain metastasis was 0.85, showing no statistically significant difference with L/Nmax of the contralateral brain (AUC = 0.89) or with L/Nmean of the contralateral cerebellar cortex (AUC = 0.89), which were the areas that were the highest in the quantitative assessment. For evaluation of gliomas, no specific candidate was confirmed among the four areas used in visual assessment, and no significant difference was seen between visual assessment and quantitative assessment. CONCLUSION: The visual assessment showed no significant difference from quantitative assessment of MET-PET with a relevant cut-off value for the differentiation of recurrent brain tumors from radiation-induced necrosis.
Assuntos
Neoplasias Encefálicas/diagnóstico por imagem , Encéfalo/patologia , Recidiva Local de Neoplasia/diagnóstico por imagem , Tomografia por Emissão de Pósitrons/métodos , Adulto , Idoso , Idoso de 80 Anos ou mais , Encéfalo/diagnóstico por imagem , Neoplasias Encefálicas/patologia , Neoplasias Encefálicas/radioterapia , Radioisótopos de Carbono/metabolismo , Diagnóstico Diferencial , Feminino , Glioma/diagnóstico por imagem , Glioma/patologia , Glioma/radioterapia , Humanos , Masculino , Metionina/metabolismo , Pessoa de Meia-Idade , Necrose , Neuroimagem , Variações Dependentes do Observador , Estudos RetrospectivosRESUMO
Assessment of myocardial viability is very important for identifying patients likely to benefit from coronary revascularization. Clinical studies have shown that positron emission tomography(PET) using [18F] 2-fluoro-2deoxy-D-glucose (FDG) can accurately identify patients with viable myocardium that are likely to benefit from revascularization procedures, in terms of improvement of left ventricular (LV) function, alleviation of heart failure symptoms, and improvement of long-term prognosis. Single photon emission computed tomography (SPECT) using perfusion tracers such as TL-201 and Tc99m-MIBI are useful to assess viability, but a problem is their particularly low specificity. FDG-PET has several advantages including higher sensitivity and specificity over perfusion tracers. This article will review myocardial metabolism, FDG-PET protocol, procedures, interpretive criteria and clinical applications as well as problems and limitations. The literature regarding diagnostic and prognostic information about viability using FDG-PET is summarized.